Contains information about title and source of a journal
Naslov:
Mutant KRAS is a druggable target for pancreatic cancer
Vir:
Proceedings of the National Academy of Sciences of the United States of America
[0027-8424]
Zorde Khvalevsky,
Elina
l. 2013,
letn. 110,
št. 51,
stran 20723
-20728